A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE)

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

Methods: Study design: The study is a retrospective multi-center chart review study. Data Source(s): All the data will be collected by CRF from inpatient and outpatient electronic medical records in every study site from January 1, 2019 to December 31, 2022. Study Population: Patients who attended the study sites between January 1, 2019 - December 31, 2022 and were diagnosed with NF1 were included in this study. Statistical Analysis: This study is purely descriptive without any formal hypotheses. Missing data for baseline characteristics will be assessed and addressed as a categorical variable with a level for missingness. All reported measures will be summarized in the study tables. Point estimates and their 95% CIs will be presented in the final analyses.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patients who attended the study sites between January 1, 2019, and December 31, 2022.

• Patients who were diagnosed with NF1(recorded with the text of type I neurofibromatosis) based on National Institutes of Health (NIH) NF1 consensus.

Locations
Other Locations
China
Xuanwu Hospital, Capital Medical University
RECRUITING
Beijing
West China Hospital, Sichuan University
RECRUITING
Chengdu
The First Affiliated Hospital of Guangxi Medical University
RECRUITING
Nanning
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
ACTIVE_NOT_RECRUITING
Shanghai
The First Affiliated Hospital of Zhengzhou University
RECRUITING
Zhengzhou
Contact Information
Primary
Zhichao Wang
shmuwzc@163.com
+86 13816382311
Time Frame
Start Date: 2019-01-01
Estimated Completion Date: 2025-02-28
Participants
Target number of participants: 2000
Sponsors
Leads: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

This content was sourced from clinicaltrials.gov